Guardant Health [GH] vs Waters [WAT] Detailed Stock Comparison

Guardant Health Inc.

NASDAQ
Loading...

Waters Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Guardant Health Inc. wins in 4 metrics, Waters Corporation wins in 15 metrics, with 0 ties. Waters Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Guardant Health Inc. Waters Corporation Better
P/E Ratio (TTM) -26.47 28.90 Waters Corporation
Price-to-Book Ratio -113.87 7.24 Waters Corporation
Debt-to-Equity Ratio -17.22 60.28 Waters Corporation
PEG Ratio -2.38 -9.39 Guardant Health Inc.
EV/EBITDA -31.17 28.78 Waters Corporation
Profit Margin (TTM) -42.39% 20.30% Waters Corporation
Operating Margin (TTM) -42.91% 33.76% Waters Corporation
EBITDA Margin (TTM) N/A 33.76% N/A
Return on Equity 419.18% 29.28% Guardant Health Inc.
Return on Assets (TTM) -15.59% 11.52% Waters Corporation
Free Cash Flow (TTM) $-233.07M $539.81M Waters Corporation
1-Year Return 167.03% 3.87% Guardant Health Inc.
Price-to-Sales Ratio (TTM) 12.07 9.65 Waters Corporation
Enterprise Value $12.36B $31.49B Waters Corporation
EV/Revenue Ratio 12.59 9.95 Waters Corporation
Gross Profit Margin (TTM) 64.63% 61.08% Guardant Health Inc.
Revenue per Share (TTM) $8 $53 Waters Corporation
Earnings per Share (Diluted) $-3.32 $10.77 Waters Corporation
Beta (Stock Volatility) 1.65 1.20 Waters Corporation
Short % of Float 10.93% 3.38% Waters Corporation

Guardant Health Inc. vs Waters Corporation Stock Performance Analysis

Loading Price Chart...

GH
WAT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Guardant Health Inc.-1.37%3.95%36.77%48.91%26.44%27.60%
Waters Corporation0.63%-1.54%8.67%23.36%-7.18%-6.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Guardant Health Inc.167.03%254.87%9.50%350.75%350.75%350.75%
Waters Corporation3.87%32.07%3.74%165.28%286.07%736.74%

Performance & Financial Health Analysis: Guardant Health Inc. vs Waters Corporation

MetricGHWAT
Market Information
Market Cap i$11.53B$30.55B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,518,232809,747
90 Day Avg. Volume i2,085,557944,136
Last Close$129.82$357.76
52 Week Range$40.35 - $135.00$275.05 - $414.15
% from 52W High-3.84%-13.62%
All-Time High$181.07 (Feb 08, 2021)$428.22 (Sep 06, 2021)
% from All-Time High-28.30%-16.45%
Growth Metrics
Quarterly Revenue Growth0.39%0.07%
Quarterly Earnings Growth0.39%-0.03%
Financial Health
Profit Margin (TTM) i-0.42%0.20%
Operating Margin (TTM) i-0.43%0.34%
Return on Equity (TTM) i4.19%0.29%
Debt to Equity (MRQ) i-17.2260.28
Cash & Liquidity
Book Value per Share (MRQ)$-0.76$43.01
Cash per Share (MRQ)$9.16$5.99
Operating Cash Flow (TTM) i$-184,760,000$652.56M
Levered Free Cash Flow (TTM) i$-88,105,872$427.16M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Guardant Health Inc. vs Waters Corporation

MetricGH (Apr 24, 2026)WAT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-26.4728.90
Forward P/E i-129.0819.04
PEG Ratio i-2.38-9.39
Price to Sales (TTM) i12.079.65
Price to Book (MRQ) i-113.877.24
Market Capitalization
Market Capitalization i$11.53B$30.55B
Enterprise Value i$12.36B$31.49B
Enterprise Value Metrics
Enterprise to Revenue i12.599.95
Enterprise to EBITDA i-31.1728.78
Risk & Other Metrics
Beta i1.651.20
Book Value per Share (MRQ) i$-0.76$43.01

Financial Statements Comparison: Guardant Health Inc. vs Waters Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGH (2025)WAT (2025)
Revenue/Sales i982.02M3.17B
Cost of Goods Sold i349.01M1.29B
COGS % of Revenue i35.5%40.7%
Gross Profit i633.01M1.88B
Gross Margin i64.5%59.3%
Research & Development i364.19M195.71M
Operating Income (EBIT) i-437.25M802.59M
Operating Margin i-44.5%25.4%
EBITDA i-373.91M1.03B
EBITDA Margin i-38.1%32.6%
Pre-Tax Income i-417.54M754.88M
Pre-Tax Income % of Revenue i-42.5%23.8%
Income Tax i-1.26M112.25M
Income Tax % of Revenue i-0.1%3.5%
Net Income (Profit) i-416.28M642.63M
Profit Margin i-42.4%20.3%

Balance Sheet & Liquidity Metrics

MetricGH (2025)WAT (2025)
Cash & Equivalents i378.20M587.83M
Total Current Assets i1.47B2.15B
Total Current Assets % of Revenue i149.3%67.8%
Total Current Liabilities i302.73M1.24B
Total Current Liabilities % of Revenue i30.8%39.2%
Long-Term Debt i1.68B999.99M
Long-Term Debt % of Revenue i171.3%31.6%
Total Shareholders Equity i-99.31M2.56B
Retained Earnings i-2.99B10.43B
Retained Earnings % of Revenue i-304.9%329.6%
Property, Plant & Equipment i158.85M824.49M

Cash Flow Statement Comparison

MetricGH (2025)WAT (2025)
Operating Cash Flow i-230.19M652.56M
Operating Cash Flow % of Revenue i-23.4%20.6%
Capital Expenditures i-48.31M-112.75M
Free Cash Flow i-233.07M539.81M
FCF Margin i-23.7%17.1%
Debt Repayment iN/A-290.00M
Common Stock Repurchase i-45.01M-14.67M

Short Interest & Institutional Ownership Analysis

MetricGHWAT
Shares Short i13.70M3.32M
Short Ratio i7.502.98
Short % of Float i10.93%3.38%
Shares Outstanding i130.64M59.55M
Float Shares i125.75M97.96M
% Held by Insiders i4.04%0.11%
% Held by Institutions i101.22%63.35%
% Held by Public i-5.26%36.54%

Dividend Analysis & Yield Comparison: Guardant Health Inc. vs Waters Corporation

MetricGHWAT
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A